Neurosterix

Neurosterix is a biotech company in Geneva, Switzerland, founded in 2024. It has raised $63.0M across 1 round, most recently a $63.0M Series A in April 2024.

Headquarters
Geneva, Geneva
Employees
11–50
Founded
2024
Total Funding
$63.0M
Last Round
$63.0M Series AApr 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Neurosterix is charting a new path in neuroscience. Founded in 2024, the company is developing next-generation medicines that fine-tune brain signaling with precision, targeting neuropsychiatric disorders that remain among the most urgent and underserved areas of medicine. Current treatments often provide only partial relief, blunting symptoms without restoring healthy brain function, and Neurosterix's work advances neuropsychiatric therapies through allosteric modulation.

Summary

It lists 11–50 employees. It has raised $63.0M in total across 1 round, most recently a $63.0M Series A round in Apr 2024. Investors include Perceptive Advisors, Perceptive Life Sciences and Acorn Bioventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AApr 2024
$63.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurosterix on Indexed.vc
<a href="https://indexed.vc/companies/neurosterix"><img src="https://indexed.vc/api/badge/company/neurosterix" alt="Neurosterix on Indexed.vc" width="260" height="76" /></a>